INFINIFLUIDICS INC
Philadelphia, PA · Biotech · Private
Very Large-Scale Microfluidic Integration (VLSMI) chip for lipid nanoparticle (LNP) production, scaling from 100 mL/hr to 100 L/hr
- Grants
- $843K
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 2
- 0 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: On-demand Continuous and Sterile Manufacturing of Injectable Drug Delivery Systems at Industrial Scale on a Portable Microfluidic Chip | $256,000 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · A Very Large-Scale Microfluidic Integration (VLSMI) chip for producing lipid nanoparticles (LNPs) for RNA vaccines and therapeutics | $293,405 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · A Very Large-Scale Microfluidic Integration (VLSMI) chip for producing lipid nanoparticles (LNPs) for RNA vaccines and therapeutics | $293,405 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1743 | PHI OPTICS INC | — | $450K |
| 1744 | Iambic Therapeutics | — | $323M |
| 1745 | AVT, Inc. | — | $170K |
| 1746 | INFINIFLUIDICS INC | — | — |
| 1747 | Airway Therapeutics, LLC | — | $54M |
| 1748 | Quoin Pharmaceuticals, Ltd. | — | $164M |
| 1749 | Tempo Therapeutics Inc | — | $34M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Microfluidic Chips For Scale-independent, Continuous, End-to-end Manufacturing Of Nanomaterialsapplication
- Microfluidic Chips For Scale-independent, Continuous, End-to-end Manufacturing Of Nanomaterialsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.